Moderna and IBM join forces to advance mRNA technology with A.I. and quantum computing

Moderna and IBM have partnered to use generative AI and quantum computing to advance mRNA technology, the core of Moderna's Covid vaccine. Moderna will access IBM's quantum computing systems to accelerate the discovery and creation of new mRNA vaccines and therapies. IBM will also provide experts to help Moderna scientists explore the use of quantum technologies. Moderna will use IBM's generative AI model to understand the characteristics of potential mRNA medicines and design a new class of vaccines and therapies.